Substituted pyrrolopyridine jak inhibitors and methods of making and using the same
AssigneeAclaris Therapeutics, Inc.
InventorsDavid Randolph ANDERSON, Susan Landis HOCKERMAN, James Robert BLINN, Eric Jon JACOBSEN
Life of this patent
Estimating the term…
Abstract
The present invention relates to new pyrrolopyridine compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibition of JAK1 and JAK3 kinase activity in a human or animal subject are also provided for the treatment diseases such as pruritus, alopecia, androgenetic alopecia, alopecia areata, vitiligo and psoriasis.
Claims25
-42. (canceled)
A method of treating a JAK1- and/or JAK3-mediated disease in a subject in need thereof comprising administering a therapeutically effective amount of a compound, or a pharmaceutically acceptable salt thereof, of the structure:
- wherein JAK1- and/or JAK3-mediated disease is treated.
Dependencies are inferred from the claim text.